How to make the best of NLRP3 inhibitors in patients with COVID-19?

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan

doi:10.1007/s00228-023-03518-z

How to make the best of NLRP₃ inhibitors in patients with COVID-19?

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1143-1144
Number of pages	2
Journal	European Journal of Clinical Pharmacology
Volume	79
Issue number	8
Early online date	9 Jun 2023
DOIs	https://doi.org/10.1007/s00228-023-03518-z
Publication status	Published - 1 Aug 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00228-023-03518-zLicence: Unspecified

Cite this

@article{23f0f4808bf74cca956fee866134d6a2,

title = "How to make the best of NLRP3 inhibitors in patients with COVID-19?",

keywords = "NLRP3 inhibitors, COVID-19, colchicine",

author = "Kow, {Chia Siang} and Ramachandram, {Dinesh Sangarran} and Hasan, {Syed Shahzad}",

year = "2023",

month = aug,

day = "1",

doi = "10.1007/s00228-023-03518-z",

language = "English",

volume = "79",

pages = "1143--1144",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",